Literature DB >> 21083376

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture.

Daša Stupica1, Lara Lusa, Tjaša Cerar, Eva Ružić-Sabljić, Franc Strle.   

Abstract

PURPOSE: Limited data exist on differences of erythema migrans patients with either positive or negative Borrelia burgdorferi sensu lato skin culture.
METHODS: We analyzed 252 adult patients with erythema migrans in whom skin biopsy specimen was cultured for the presence of B. burgdorferi sensu lato. Evaluations of epidemiological, clinical, and microbiological findings were conducted at baseline, 14 days, 2, 6, and 12 months after treatment with either doxycycline or cefuroxime axetil.
RESULTS: One hundred fifty-one (59.9%) patients had positive skin culture (86.9% B. afzelii, 8.0% B. garinii, 5.1% B. burgdorferi sensu stricto) and 101 (40.1%) had negative skin culture. Patients in the culture-positive and culture-negative groups were comparable for the basic demographic, epidemiological, clinical, and laboratory characteristics at presentation. Statistically significantly worse selected treatment outcome parameters in the culture-positive group compared with the culture-negative group were established during follow-up. Treatment failure was documented in two patients who were culture positive and in none in the culture-negative group.
CONCLUSIONS: Although findings for the pretreatment characteristics were comparable between the erythema migrans skin culture-positive and culture-negative patients, some parameters indicate that borrelia skin culture positivity may predict a less-favorable treatment outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21083376     DOI: 10.1089/vbz.2010.0018

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  8 in total

Review 1.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

2.  Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings.

Authors:  Daša Stupica; Lara Lusa; Vera Maraspin; Petra Bogovič; Darja Vidmar; Maria O'Rourke; Andreas Traweger; Ian Livey; Franc Strle
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

3.  Clinical characteristics associated with Borrelia burgdorferi sensu lato skin culture results in patients with erythema migrans.

Authors:  Franc Strle; Lara Lusa; Eva Ružić-Sabljić; Vera Maraspin; Stanka Lotrič Furlan; Jože Cimperman; Katarina Ogrinc; Tereza Rojko; Jerneja Videčnik Zorman; Daša Stupica
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

4.  medplot: a web application for dynamic summary and analysis of longitudinal medical data based on R.

Authors:  Črt Ahlin; Daša Stupica; Franc Strle; Lara Lusa
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  Validation of cellular tests for Lyme borreliosis (VICTORY) study.

Authors:  F R van de Schoor; M E Baarsma; S A Gauw; L A B Joosten; B J Kullberg; C C van den Wijngaard; J W Hovius
Journal:  BMC Infect Dis       Date:  2019-08-20       Impact factor: 3.090

Review 6.  The evolving story of Borrelia burgdorferi sensu lato transmission in Europe.

Authors:  Antje Steinbrink; Katharina Brugger; Gabriele Margos; Peter Kraiczy; Sven Klimpel
Journal:  Parasitol Res       Date:  2022-02-05       Impact factor: 2.289

7.  A prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands.

Authors:  Agnetha Hofhuis; Tineke Herremans; Daan W Notermans; Hein Sprong; Manoj Fonville; Joke W B van der Giessen; Wilfrid van Pelt
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

8.  Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR.

Authors:  Maria O'Rourke; Andreas Traweger; Lara Lusa; Dasa Stupica; Vera Maraspin; P Noel Barrett; Franc Strle; Ian Livey
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.